[pending] Lezyne USA Recalls Bicycle Floor Pumps Due to Serious Injury Hazard
Pending LLM rewrite. Source: CPSC 26078.
- Product
- Lezyne Pressure Over Drive Bicycle Floor Pumps
- Category
- Consumer Product
- Distribution
- Distributed nationwide
State
19,787 recalls have nationwide distribution and so reach Iowa. 0 additional recalls listed Iowa specifically in their distribution scope.
Most US product recalls have nationwide distribution — the manufacturer ships into every state and the recall sweeps the same way. We include those in this listing because they affect Iowa consumers even though the source notice doesn’t name the state. State-specific recalls are usually for products with regional distribution (a regional dairy, a local store brand) or where the agency was able to narrow the affected shipments to specific destinations.
If you’re checking whether a recall affects your purchase, the recall detail page lists the exact production lot codes, UPCs, and best-by dates. Match those against your package — distribution scope is a starting filter, not the final answer.
Pending LLM rewrite. Source: CPSC 26078.
Pending LLM rewrite. Source: CPSC 26073.
Pending LLM rewrite. Source: CPSC 26068.
Pending LLM rewrite. Source: NHTSA 25V368000.
Pending LLM rewrite. Source: CPSC 26075.
Pending LLM rewrite. Source: CPSC 26071.
Pending LLM rewrite. Source: FDA_DEVICE Z-0317-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0332-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0136-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0357-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0328-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0362-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0113-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0408-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0403-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0346-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0127-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0394-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0320-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0135-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0345-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0108-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0352-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0141-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-0413-2026.